Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about ImmunoGen Inc
Recent news which mentions ImmunoGen Inc
Cramer's Lighting Round: Arm is 'one you want to own'
January 05, 2024
Tags
Market Outlook
stocks
Investing
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
ImmunoGen Inc
Business News
Pfizer Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
December 07, 2023
Tags
Business News
ImmunoGen Inc
Economy
From
CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
Tags
Acquisitions
US: News
Abbvie Inc
From
CNBC.com News
Cramer's Lightning Round: Sell Immunogen and take the gain
June 09, 2023
Tags
Mad Money
U/S/ Markets
Investment Strategy
From
CNBC.com News
Stocks making the biggest moves midday: Palo Alto Networks, 3M, Amedisys, Target and more
June 05, 2023
Tags
Ford Motor Co
3M Co
Finance
From
CNBC.com News
Stocks making the biggest moves midday: CVS Health, Eli Lilly, Clorox, Yum and more
May 03, 2023
Tags
stocks
Kraft Heinz Co
Estee Lauder Companies Inc
From
CNBC.com News
Stocks making the biggest moves midday: Netflix, Cal-Maine Foods, Southwest and more
December 29, 2022
Tags
Breaking News: Markets
Netflix Inc
Tesla Inc
From
CNBC.com News
Stocks making the biggest moves premarket: Tesla, Cal-Maine, Southwest and others
December 29, 2022
Tags
Market Insider
Apple Inc
Southwest Airlines Co
From
CNBC.com News
Cramer's lightning round: I still see another bad quarter ahead for Ford Motor
November 22, 2022
Tags
Business News
Vista Outdoor Inc
ImmunoGen Inc
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.